XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 52,491,900 $ 142,823,016
Cash equivalent - reverse repurchase agreements 50,000,000 0
Marketable securities 30,545,450 0
Prepaid expenses and other current assets 7,808,596 4,987,317
Total current assets 140,845,946 147,810,333
Right-of-use assets 451,867 510,814
Fixed assets, net 4,079 5,764
Total assets 141,301,892 148,326,911
Current liabilities:    
Accounts payable 280,299 1,338,057
Accrued expenses 5,944,419 5,536,464
Current portion of debt 15,204,698 15,146,546
Operating lease liabilities 247,021 239,183
Total current liabilities 21,676,437 22,260,250
Long-term debt, net of current portion 0 0
Deferred collaboration revenue, long term 6,000,000 6,000,000
Operating lease liabilities, long-term 206,014 271,631
Total liabilities 27,882,451 28,531,881
Commitments and contingencies (Notes 13, 14, and 15)
Stockholders' equity:    
Preferred stock, $0.001 par value, 15,000,000 shares authorized, none issued and outstanding 0 0
Common stock, voting, $0.001 par value; 150,000,000 authorized and 59,414,489 and 59,195,951 shares issued and outstanding, respectively 59,415 59,196
Additional paid-in capital 515,704,325 513,994,982
Accumulated other comprehensive loss (3,029) 0
Accumulated deficit (402,341,270) (394,259,148)
Total stockholders’ equity 113,419,441 119,795,030
Total liabilities and stockholders’ equity $ 141,301,892 $ 148,326,911